
Collegium Pharmaceutical, Inc.: shareholders and insiders
Price
$25.48
November 16, 2026Market cap $809M
What Ploutos Investor adds for Collegium Pharmaceutical
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from 2016
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
Insiders and their shares
Purchases and sales by officers and directors from Nov 16, 2025 to Jun 10, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$4.4M
6 people
From Nov 16, 2025 to Nov 16, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan82%
- The rest18%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 16, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $3.4M by 5 people
- 2025: no buys, sold $1.0M by 2 people
- 2026: no buys, sold $3.4M by 5 people
- Jun 8, 2026Gino SantiniDirectorKind
- May 18, 2026John Gordon FreundKind
- May 15, 2026John Gordon FreundKind
- May 13, 2026Nancy LurkerKind
- May 11, 2026Garen G BohlinKind
- Mar 18, 2026David DieterEVP & General CounselKind10b5-1
- Mar 9, 2026David DieterEVP & General CounselKind10b5-1
- Mar 3, 2026Scott DreyerEVP & Chief Commercial OfficerKind10b5-1
- Mar 3, 2026Scott DreyerEVP & Chief Commercial OfficerKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | Gino SantiniDirector | 8,700 | $16.49 | $143.5K | Form 4 | |
| May 18, 2026 | John Gordon Freund | 20 | $34.05 | $681 | Form 4 | |
| May 15, 2026 | John Gordon Freund | 4,127 | $34.54 | $142.5K | Form 4 | |
| May 13, 2026 | Nancy Lurker | 4,500 | $35.97 | $161.9K | Form 4 | |
| May 11, 2026 | Garen G Bohlin | 8,700 | $37.18 | $323.5K | Form 4 | |
| Mar 18, 2026 | David DieterEVP & General Counsel | 10b5-1 | 14.0K | $34.92 | $488.0K | Form 4 |
| Mar 9, 2026 | David DieterEVP & General Counsel | 10b5-1 | 6,224 | $36.65 | $228.1K | Form 4 |
| Mar 3, 2026 | Scott DreyerEVP & Chief Commercial Officer | 10b5-1 | 46.4K | $40.36 | $1.9M | Form 4 |
| Mar 3, 2026 | Scott DreyerEVP & Chief Commercial Officer | 10b5-1 | 3,559 | $40.99 | $145.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 10, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by COLL's officers and directors from 2015 up to November 15, 2025, 11 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 6 more, back to 2015
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Share of class15.6%
- Integrated Core Strategies (US) LLCwith 3 more personsShare of class7.40%
- Janus Henderson GroupShare of class5.80%
- State StreetShare of class5.40%
- Fuller & Thaler Asset Management, Inc.Share of class5.03%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15.6% | 5.00M | Apr 28, 2025 | 13G/A | |
| Integrated Core Strategies (US) LLCwith 3 more persons | 7.40% | 2.40M | Oct 8, 20263 filings since May 12, 2026 | 13G/A | |
| Janus Henderson Group | 5.80% | 1.83M | May 15, 2026 | 13G | |
| State Street | 5.40% | 1.77M | Nov 10, 2026 | 13G | |
| Fuller & Thaler Asset Management, Inc. | 5.03% | 1.63M | Aug 14, 2026 | 13G |
Fell to 5% or less (8)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Invesco Ltd.3.90%Nov 10, 202613G/A
- Vanguard Capital Management4.97%Oct 30, 202613G/A
- Principal Global Investors4.70%Oct 29, 202613G/A
- Eventide Asset Management, LLC4.50%May 15, 202613G/A
- Renaissance Technologies LLC4.53%May 14, 202613G/A
- The Vanguard Group0.00%Mar 26, 202613G/A
- Rubric Capital Management LP4.73%Feb 13, 202613G/A
- Pacer US Small Cap Cash Cows ETF1.06%May 2, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+3.1%
- Millennium Mgmt (Englander)In the quarter+104%
- Point72 (Cohen)In the quarter
- D.E. ShawIn the quarter-36%
- Citadel Advisors (Griffin)In the quarter-43%
- AQR CapitalIn the quarter+11%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 1.41M | +3.1% | $31M | 0.04% |
| Millennium Mgmt (Englander) | 736.9K | +104% | $27M | 0.02% |
| Point72 (Cohen) | 114.0K | $4.1M | 0.01% | |
| D.E. Shaw | 338.4K | -36% | $12M | 0.01% |
| Citadel Advisors (Griffin) | 68.6K | -43% | $2.5M | 0.00% |
| AQR Capital | 149.8K | +11% | $5.4M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 16.9% of its shares outstanding were held short, -2.6% since the report before.
- Shares held short
- 5.38M
- 16.9%
- Since the report before5.52M on Sep 30, 2026
- -2.6%
- 7.2
- 749.9K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 79%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 6.01M
- Nov 15, 2023: Shares held short 6.80M
- Nov 30, 2023: Shares held short 6.60M
- Dec 15, 2023: Shares held short 6.62M
- Dec 29, 2023: Shares held short 6.38M
- Jan 12, 2024: Shares held short 6.35M
- Jan 31, 2024: Shares held short 6.76M
- Feb 15, 2024: Shares held short 6.82M
- Feb 29, 2024: Shares held short 6.72M
- Mar 15, 2024: Shares held short 7.01M
- Mar 28, 2024: Shares held short 7.12M
- Apr 15, 2024: Shares held short 6.99M
- Apr 30, 2024: Shares held short 6.86M
- May 15, 2024: Shares held short 6.93M
- May 31, 2024: Shares held short 6.85M
- Jun 14, 2024: Shares held short 6.63M
- Jun 28, 2024: Shares held short 6.94M
- Jul 15, 2024: Shares held short 6.92M
- Jul 31, 2024: Shares held short 6.22M
- Aug 15, 2024: Shares held short 6.11M
- Aug 30, 2024: Shares held short 6.29M
- Sep 13, 2024: Shares held short 6.35M
- Sep 30, 2024: Shares held short 5.94M
- Oct 15, 2024: Shares held short 6.15M
- Oct 31, 2024: Shares held short 6.21M
- Nov 15, 2024: Shares held short 6.29M
- Nov 29, 2024: Shares held short 6.11M
- Dec 13, 2024: Shares held short 5.99M
- Dec 31, 2024: Shares held short 5.98M
- Jan 15, 2025: Shares held short 5.62M
- Jan 31, 2025: Shares held short 5.68M
- Feb 14, 2025: Shares held short 5.21M
- Feb 28, 2025: Shares held short 5.41M
- Mar 14, 2025: Shares held short 5.27M
- Mar 31, 2025: Shares held short 4.53M
- Apr 15, 2025: Shares held short 4.47M
- Apr 30, 2025: Shares held short 4.56M
- May 15, 2025: Shares held short 5.08M
- May 30, 2025: Shares held short 4.90M
- Jun 13, 2025: Shares held short 4.82M
- Jun 30, 2025: Shares held short 4.35M
- Jul 15, 2025: Shares held short 4.21M
- Jul 31, 2025: Shares held short 4.22M
- Aug 15, 2025: Shares held short 4.42M
- Aug 29, 2025: Shares held short 4.32M
- Sep 15, 2025: Shares held short 4.45M
- Sep 30, 2025: Shares held short 5.19M
- Oct 15, 2025: Shares held short 5.23M
- Oct 31, 2025: Shares held short 5.38M
- Nov 14, 2025: Shares held short 5.68M
- Nov 28, 2025: Shares held short 5.88M
- Dec 15, 2025: Shares held short 5.35M
- Dec 31, 2025: Shares held short 5.42M
- Jan 15, 2026: Shares held short 5.59M
- Jan 30, 2026: Shares held short 4.79M
- Feb 13, 2026: Shares held short 4.77M
- Feb 27, 2026: Shares held short 4.60M
- Mar 13, 2026: Shares held short 4.28M
- Mar 31, 2026: Shares held short 5.53M
- Apr 15, 2026: Shares held short 6.03M
- Apr 30, 2026: Shares held short 5.94M
- May 15, 2026: Shares held short 5.97M
- May 29, 2026: Shares held short 5.66M
- Jun 15, 2026: Shares held short 5.33M
- Jun 30, 2026: Shares held short 5.47M
- Jul 15, 2026: Shares held short 5.23M
- Jul 31, 2026: Shares held short 5.08M
- Aug 14, 2026: Shares held short 6.52M
- Aug 31, 2026: Shares held short 6.06M
- Sep 15, 2026: Shares held short 5.68M
- Sep 30, 2026: Shares held short 5.52M
- Oct 15, 2026: Shares held short 5.38M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading51.4% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 51.4% of the shares in the reported trades were short sales, against 55.6% in the 14 before.
- Last 14 sessionsOct 27, 2026 – Nov 13, 2026
- 51.4%
- The 14 beforeOct 7, 2026 – Oct 26, 2026
- 55.6%
- Change
- -4.2 pts
- Short sales a dayon average, of 212.4K shares
- 109.2K
- More than atof 3,649 US-listed companies, same days
- 55%
- Median of alleight in ten from 34.6% to 63.4%
- 50.1%
- Short sales
- Oct 7, 2026: Short sales 67%
- Oct 8, 2026: Short sales 64.8%
- Oct 9, 2026: Short sales 56.6%
- Oct 12, 2026: Short sales 62.5%
- Oct 13, 2026: Short sales 52.6%
- Oct 14, 2026: Short sales 64.4%
- Oct 15, 2026: Short sales 54.8%
- Oct 16, 2026: Short sales 55%
- Oct 19, 2026: Short sales 43.6%
- Oct 20, 2026: Short sales 54.7%
- Oct 21, 2026: Short sales 57.8%
- Oct 22, 2026: Short sales 45.7%
- Oct 23, 2026: Short sales 53.1%
- Oct 26, 2026: Short sales 57.1%
- Oct 27, 2026: Short sales 55.5%
- Oct 28, 2026: Short sales 57.1%
- Oct 29, 2026: Short sales 41.9%
- Oct 30, 2026: Short sales 58%
- Nov 2, 2026: Short sales 62.1%
- Nov 3, 2026: Short sales 67.2%
- Nov 4, 2026: Short sales 50.7%
- Nov 5, 2026: Short sales 55.4%
- Nov 6, 2026: Short sales 44.1%
- Nov 9, 2026: Short sales 42.3%
- Nov 10, 2026: Short sales 52%
- Nov 11, 2026: Short sales 41.6%
- Nov 12, 2026: Short sales 43.3%
- Nov 13, 2026: Short sales 53.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Rubric Capital Management LPTenPercentOwnerDirectly–
- Joseph CiaffoniPresident and CEODirectly275.0K
- Colleen TupperEVP & Chief Financial OfficerDirectly126.7K
- Gino SantiniDirectorDirectly112.5K
- Shirley R. KuhlmannEVP and General CounselDirectly108.1K
- John Gordon FreundDirectorDirectly84.0K
- David DieterEVP & General CounselDirectly77.1K
- Scott DreyerEVP & Chief Commercial OfficerDirectly75.3K
- Thomas B SmithEVP and Chief Medical OfficerDirectly70.3K
- John A. FallonDirectorDirectly64.6K
- Garen G BohlinDirectorDirectly62.3K
- Rita J. Balice-GordonDirectorDirectly52.6K
- Nancy LurkerDirectorDirectly18.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Rubric Capital Management LPTenPercentOwner | – | 3.13M | Aug 13, 2025 | Form 4 |
| Joseph CiaffoniPresident and CEO | 275.0K | – | Dec 21, 2023 | Form 4 |
| Colleen TupperEVP & Chief Financial Officer | 126.7K | – | Nov 6, 2025 | Form 4 |
| Gino SantiniDirector | 112.5K | – | Jun 8, 2026 | Form 4 |
| Shirley R. KuhlmannEVP and General Counsel | 108.1K | – | Mar 6, 2025 | Form 4 |
| John Gordon FreundDirector | 84.0K | 23.1K | May 18, 2026 | Form 4 |
| David DieterEVP & General Counsel | 77.1K | – | Mar 18, 2026 | Form 4 |
| Scott DreyerEVP & Chief Commercial Officer | 75.3K | – | Mar 3, 2026 | Form 4 |
| Thomas B SmithEVP and Chief Medical Officer | 70.3K | – | Aug 29, 2025 | Form 4 |
| John A. FallonDirector | 64.6K | – | Nov 12, 2025 | Form 4 |
| Garen G BohlinDirector | 62.3K | – | May 11, 2026 | Form 4 |
| Rita J. Balice-GordonDirector | 52.6K | – | Dec 5, 2025 | Form 4 |
| Nancy LurkerDirector | 18.0K | – | May 13, 2026 | Form 4 |
A lower bound: it counts only the 13 officers and directors with a market trade since Nov 17, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.07%
- IJRiShares Core S&P Small-Cap ETFWeight in the fund0.06%
- SPSMState Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETFWeight in the fund0.06%
- IWMiShares Russell 2000 ETFWeight in the fund0.04%
- AVUVAvantis U.S. Small Cap Value ETFWeight in the fund0.03%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.03%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.01%
- VHTVanguard Health Care Index FundWeight in the fund0.01%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.01%
17 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 244
- Q4 2025: Managers 279
- Q1 2026: Managers 270
- Q2 2026: Managers 279
Institutional investors by quarter
The fund managers holding COLL, quarter by quarter, from Q2 2015 to Q2 2025, 41 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 279 managers held 39.46M shares, worth $1.4B. During the quarter 45 opened a position, 36 closed one, 116 added and 82 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+6.0%
- Jupiter TopcoIn the quarter
- InvescoIn the quarter+18%
- Fuller & Thaler Asset ManagementIn the quarter+8.9%
- Principal Financial GroupIn the quarter+26%
- State StreetIn the quarter+7.3%
- Massachusetts Financial ServicesIn the quarter+2.9%
- Vanguard Capital ManagementIn the quarter+3.5%
- Renaissance TechnologiesIn the quarter-7.0%
- Eventide Asset ManagementIn the quarter-4.4%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 5.44M | +6.0% | $197M |
| Jupiter Topco | 2.15M | $78M | |
| Invesco | 1.88M | +18% | $68M |
| Fuller & Thaler Asset Management | 1.63M | +8.9% | $59M |
| Principal Financial Group | 1.63M | +26% | $59M |
| State Street | 1.53M | +7.3% | $55M |
| Massachusetts Financial Services | 1.41M | +2.9% | $51M |
| Vanguard Capital Management | 1.38M | +3.5% | $50M |
| Renaissance Technologies | 1.37M | -7.0% | $49M |
| Eventide Asset Management | 1.36M | -4.4% | $49M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Collegium Pharmaceutical's filings show?
Who buys and sells is one part of Collegium Pharmaceutical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have COLL's insiders bought or sold?
From Jun 10, 2026 to Jun 10, 2026 Collegium Pharmaceutical's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold COLL?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $31M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.